Product Availability Update

Promega Manufacturing and Delivery Systems continue to be fully operational during the COVID-19 outbreak. Our teams are in regular contact with suppliers and distributors worldwide and are taking all steps necessary to address both demands for diagnostic tools and reliable delivery of all products as quickly as possible. Learn more

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Anti-PARP p85 Fragment pAb Technical Bulletin

Instructions for Use of Product(s)
G7341

Literature # TB273

Anti-PARP p85 Fragment pAb is a polyclonal antibody directed against the 85kDa caspase-cleaved fragment (p85) of human poly (ADP-ribose) polymerase (PARP). Anti-PARP p85 Fragment pAb specifically detects the 85kDa (apparent molecular weight) fragment of PARP that results from caspase cleavage and does not detect the 116kDa intact PARP molecule. Its specificity for the cleaved form of PARP makes this antibody a novel marker to detect apoptosis. The antibody is designed for use as an immunocytochemical/immunohistochemical marker for apoptosis in cells and tissues and can be used with standard fixatives and immunohistochemical procedures. Anti-PARP p85 Fragment pAb provides a convenient and simple method to monitor apoptosis in situ. This antibody can be used with dual labeling techniques in conjunction with TUNEL assays for a more complete analysis of the various stages of apoptosis.

Printed in USA. Revised 7/10.